Related Experiment Video
Updated: Aug 30, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Expression of mos in ependymal gliomas
Athanasios Athanasiou1, Branko Perunovic, Robert D Quilty
1Department of Neurosurgery, Frenchay Hospital, Bristol, England.
Abstract:
The c-mos gene and its protein product mos, components of the mitogen-activated protein kinase transduction pathway, are known to be involved in the control of meiosis and mitosis. Apart from our previous studies on lung carcinomas and astrocytic gliomas, little has been published about its role in human neoplasia. The aim of this study was to investigate the expression of mos in ependymal neoplasms and to correlate it with tumor grade, proliferative fraction, and clinical behavior. We studied mos expression in biopsy specimens from 34 patients with ependymomas. Intracytoplasmic immunopositivity for mos was found in 16 (47%) and was associated significantly with tumor grade: 5 (24%) of 21 grade II ependymomas; 11 (85%) of 13 grade III anaplastic ependymomas (P < .01). Tumors with an MIB-1 labeling index of more than 4% were significantly more likely than those with a lower proliferative fraction to be immunopositive for mos (P = .012). Expression of mos showed a significant negative association with recurrence-free interval (P = .05) but not with overall survival. Our results suggest that overexpression of mos identifies a biologically aggressive subgroup of ependymal tumors and may be involved in their neoplastic progression.
Insights
Mos protein expression in ependymal tumors indicates a more aggressive biological profile. Overexpression of mos is linked to higher tumor grade and increased proliferation, suggesting a role in neoplastic progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The c-mos gene and its protein product, mos, are key regulators in the mitogen-activated protein kinase pathway, influencing cell division.
- Limited research exists on the role of mos in human neoplasia, particularly in ependymal tumors.
Purpose of the Study:
- To investigate mos expression in ependymal neoplasms.
- To correlate mos expression with tumor grade, proliferative fraction, and clinical behavior.
Main Methods:
- Mos expression was analyzed using immunohistochemistry in 34 ependymoma biopsy specimens.
- Correlation with tumor grade (WHO II vs. III), MIB-1 labeling index, recurrence-free interval, and overall survival was performed.
Main Results:
- Mos immunopositivity was detected in 47% of ependymomas, significantly associated with higher tumor grade (grade III anaplastic ependymomas).
- Higher mos expression correlated with increased proliferative fraction (MIB-1 labeling index > 4%).
- Mos expression showed a negative association with recurrence-free interval, but not overall survival.
Conclusions:
- Overexpression of mos identifies a biologically aggressive subset of ependymal tumors.
- Mos may play a role in the progression of ependymal neoplasms.
- Mos expression serves as a potential biomarker for aggressive ependymal tumor behavior.
Related Concept Videos
Encephalitis l: Introduction
Influenza
Encephalitis ll: Pathophysiology
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Viral Meningitis

